Fulminant Hemorrhagic Vasculopathy Associated with COVID-19
https://doi.org/10.5281/zenodo.10391104
PDF

How to Cite

Michelle Bravo, Ghada Elhawary, Jayaji Moré, Ester Sherman, Nicole E. Casson, 4, Fawaz Al-Mufti, & Stephan A. Mayer. (2023). Fulminant Hemorrhagic Vasculopathy Associated with COVID-19. Journal of Vascular and Interventional Neurology, 12(2). Retrieved from https://ojs.jvin.org/index.php/jvin/article/view/113

Abstract

Background— Coronavirus disease 2019 (COVID-19)–related neurologic complications remain poorly
understood. Current literature demonstrates that COVID-19 has been associated with cerebral microbleeds and
leukoencephalopathy in as many 30% of critically-ill patients who undergo magnetic resonance imaging suggestive
of endothelial inflammation and thrombotic microangiopathy.
Case Description— We report a patient who presented with the sudden onset of status epilepticus and coma.

Clinical and neuroimaging findings suggested a diffuse novel severe acute respiratory syndrome coronavirus (SARS-
CoV-2)–induced hemorrhagic vasculopathy. Her level of consciousness improved dramatically with high dose

corticosteroids, and she made a good recovery.
Conclusions— We report a patient with COVID-19 who developed clinical syndrome and radiological findings
most consistent with diffuse cerebral vasculitis.

https://doi.org/10.5281/zenodo.10391104
PDF
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2023 Journal of Vascular and Interventional Neurology

Downloads

Download data is not yet available.